Sofinnova Investments, Inc. Y M Abs Therapeutics, Inc. Transaction History
Sofinnova Investments, Inc.
- $1.8 Billion
- Q2 2024
A detailed history of Sofinnova Investments, Inc. transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Sofinnova Investments, Inc. holds 2,194,278 shares of YMAB stock, worth $32.3 Million. This represents 1.47% of its overall portfolio holdings.
Number of Shares
2,194,278
Previous 2,194,278
-0.0%
Holding current value
$32.3 Million
Previous $35.7 Million
25.71%
% of portfolio
1.47%
Previous 2.08%
Shares
2 transactions
Others Institutions Holding YMAB
# of Institutions
97Shares Held
23.8MCall Options Held
19.4KPut Options Held
300-
Paradigm Biocapital Advisors LP New York, NY3.87MShares$56.9 Million1.89% of portfolio
-
Black Rock Inc. New York, NY2.94MShares$43.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.96MShares$28.8 Million0.0% of portfolio
-
Polar Capital Holdings PLC London, X01.83MShares$26.9 Million0.13% of portfolio
-
Cormorant Asset Management, LP Boston, MA1.45MShares$21.3 Million1.35% of portfolio
About Y-mAbs Therapeutics, Inc.
- Ticker YMAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,719,500
- Market Cap $643M
- Description
- Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...